Planta Medica · 2010 · 33 citations · 10 references
PharmacyMedicinal ChemistryPharmacologyChromatographic AnalysisDrug DiscoveryStructure-activity RelationshipsHeterocyclic ChemistryPhenolic Compound AnalysisStructure-activity Relationship AnalysisActive Compound IsolationChromatographic Analysis Of PhenolicsLignan BiosynthesisMedicinal Aromatic PlantsPhenylpropanoid Glycosides
Using exhaustive chromatographic separation we have isolated (-)-tigloyl-deangeloyl-gomisin F as a novel dibenzocyclooctadiene lignan from schisandra chinensis. With the help of HPLC, we further isolated (+)-schisandrin, (+)-deoxyschisandrin, (+)-γ-schisandrin, (-)-gomisin J, (+)-gomisin A, (-)-gomisin N, (-)-tigloyl-gomisin P, (-)-wuweizisu C, (-)-gomisin D, rubrisandrin A, (-)-gomisin G, (+)-gomisin K (3) and (-)-schisantherin C. A full NMR description of (-)-schisantherin C was carried out with the aim to confirm previous reports of its structure. Compounds isolated were identified on the basis of UV, IR, (1)H- and (13)C-NMR and MS. The cytotoxicity of lignans was tested for the BY-2 cell line alone and as a synergistic effect with the cytotoxic agent camptothecin. Lignans showed various toxicity and synergistic and antagonistic effects on camptothecin-induced cytotoxicity. Cytotoxicity against colon cancer cell line LoVo was also tested.
10
Lignans in treatment of cancer and other diseases†
Kuo‐Hsiung Lee, Zhiyan Xiao · Phytochemistry Reviews · 2003 · 101 citations
Medicine, Oncology, Pharmacology +12
Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells
Ling Li, Qinghua Lu, Yanwei Shen et al. · Biochemical Pharmacology · 2006 · 80 citations
Medicine, Oncology, Pharmacology +17